<DOC>
	<DOC>NCT01073618</DOC>
	<brief_summary>This is non-interventional study of voriconazole IV formulation in clinical use, which was mandated by the Korean government agency following the approval of Vfend in the Republic of Korea.</brief_summary>
	<brief_title>Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of VfendÂ® IV</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Invasive aspergillosis and other serious fungal infections.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>voriconazole</keyword>
	<keyword>Korea</keyword>
	<keyword>invasive fungal infection</keyword>
</DOC>